Nuclear p53-mediated repression of autophagy involves PINK1 transcriptional down-regulation

Abstract

p53 is a transcription factor that is implicated in the control of both apoptotic and autophagic cell death. This tumor suppressor elicits both pro-autophagic and anti-autophagic phenotypes depending of its intracellular localization. The ability of p53 to repress autophagy has been exclusively associated to its cytoplasmic localization. Here, we show that transcriptional activity of p53 also contributes to autophagy down-regulation. Thus, nuclear p53 controls PINK1, a key protein involved in the control of mitophagy, by repressing its promoter activity, protein and mRNA levels, ex-vivo and in vivo. We establish that deletion of an identified p53 responsive element on PINK1 promoter impacts p53-mediated PINK1 transcriptional repression and we demonstrate a p53-PINK1 physical interaction by chromatin immunoprecipitation. Accordingly, we show that only nuclear p53 accounts for its ability to repress PINK1 gene transcription. Further, we demonstrate ex-vivo and in vivo that p53 invalidation in human cells increases LC3 maturation as well as optineurin and NDP52 autophagy receptors expression and down-regulates TIM23, TOM20 and HSP60 mitophagy markers. Importantly, this phenotype is mimicked by TP53 invalidation in mice brain. Finally, by combining pharmacological and genetic approaches, we show that the p53-mediated negative regulation of autophagy is PINK1-dependent. Thus pifithrin-α-mediated blockade of p53 transcriptional activity enhances LC3 maturation and reduces p62, TIM23, TOM20 and HSP60 protein levels. This pifithrin-α-associated pro-mitophagy phenotype is fully abolished by PINK1 depletion. This data unravels a novel pathway by which nuclear p53 can repress autophagy/mitophagy that could underlie important dysfunctions in both neurodegenerative and cancer diseases.

PTEN inhibition attenuates endothelial cell apoptosis in coronary heart disease via modulating the AMPK–CREB–Mfn2‐mitophagy signaling pathway

“…However, this protective mitophagy was significantly inhibited by ox-LDL (Dasa et al, 2018;Lin et al, 2018). Therefore, our findings provide further insight into the mechanism of mitochondrial injury induced by the inflammatory response Goiran et al, 2018), which also provide a potential target to increase mitochondrial resistance against inflammatory damage.…”

Toward understanding genomic instability, mitochondrial dysfunction and aging

“…First, SIRT1 deacetylates and inactivates p53. This p53 was recently shown to repress the promoter activity, protein, and mRNA levels of PINK1, which downregulates mitophagy . SIRT1 also stabilizes the MMP, most likely through regulation of PGC1α and mitochondrial uncoupling protein 2 (UCP2).…”

“…The FEBS Journal 286 (2019) 1058-1073 Published 2018. This article is a U.S. Government work and is in the public domain in the USA PINK1, which downregulates mitophagy [120]. SIRT1 also stabilizes the MMP, most likely through regulation of PGC1a and mitochondrial uncoupling protein 2 (UCP2).…”

The glycine locating at random coil of picornaviruses VP3 enhances viral pathogenicity by targeting p53 to promote apoptosis and autophagy

“…The multifunction of p53 depending of its intracellular localization. Indeed, p53 is a well-characterized transcription factor that transactivates a number of genes related to apoptosis and autophagy, such as Bid (63), Bax (64), Fas (65), Noxa (66), Puma (67), damage-regulated autophagy modulator (Dram) (68), PTEN-induced kinase 1 (PINK1)(69) and Isg20L1 (70). Indisputably, the sub-cellular location in which p53 performs the above function is the nucleus.…”